Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Toshio Fujino, M.D., Ph.D.

Concepts (106)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Toshio Fujino's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Toshio Fujino has written about over time.
Hodgkin Disease, 1 publications between 2014 and 2014, average publication date September 2014. Urinary Bladder Neoplasms, 1 publications between 2014 and 2014, average publication date September 2014. Pneumonectomy, 3 publications between 2018 and 2020, average publication date February 2019. Cell Transformation, Neoplastic, 1 publications between 2019 and 2019, average publication date July 2019. Leukemia, 1 publications between 2019 and 2019, average publication date July 2019. Precursor Cells, B-Lymphoid, 1 publications between 2019 and 2019, average publication date July 2019. Acrylamides, 2 publications between 2018 and 2021, average publication date December 2019. Quinazolines, 2 publications between 2018 and 2021, average publication date April 2020. Lung Neoplasms, 20 publications between 2016 and 2023, average publication date June 2020. Drug Resistance, Neoplasm, 11 publications between 2018 and 2023, average publication date October 2020. Protein Kinase Inhibitors, 12 publications between 2018 and 2023, average publication date October 2020. Carcinoma, Non-Small-Cell Lung, 9 publications between 2018 and 2023, average publication date November 2020. Mutation, 16 publications between 2018 and 2023, average publication date December 2020. Proto-Oncogene Proteins c-met, 4 publications between 2019 and 2022, average publication date January 2021. Aniline Compounds, 3 publications between 2018 and 2023, average publication date March 2021. Exons, 6 publications between 2018 and 2023, average publication date March 2021. Carcinoma, 1 publications between 2021 and 2021, average publication date September 2021. Pyridazines, 1 publications between 2022 and 2022, average publication date June 2022. Genes, erbB-1, 1 publications between 2023 and 2023, average publication date September 2023.

To see the data from this visualization as text, click here.
Fujino's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (106)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.